BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16574244)

  • 21. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL; Thompson PA
    J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses to free lipopolysaccharide and Escherichia coli by normal human intestinal macrophages, following their migration out of the lamina propria.
    Austin AS; Judge HM; Robins RA; Cockayne A; Mahida YR
    Scand J Immunol; 2005 Jun; 61(6):575-84. PubMed ID: 15963053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference.
    Wu TT; Chen TL; Chen RM
    Toxicol Lett; 2009 Dec; 191(2-3):195-202. PubMed ID: 19735705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1 beta gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells.
    Chen TL; Chang CC; Lin YL; Ueng YF; Chen RM
    Toxicol Appl Pharmacol; 2009 Oct; 240(1):15-25. PubMed ID: 19540866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: potential link with metabolic complications.
    Nakarai H; Yamashita A; Nagayasu S; Iwashita M; Kumamoto S; Ohyama H; Hata M; Soga Y; Kushiyama A; Asano T; Abiko Y; Nishimura F
    Innate Immun; 2012 Feb; 18(1):164-70. PubMed ID: 21239459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypsin inhibits lipopolysaccharide signaling in macrophages via toll-like receptor 4 accessory molecules.
    Komatsu H; Shimose A; Shimizu T; Mukai Y; Kobayashi J; Ohama T; Sato K
    Life Sci; 2012 Aug; 91(3-4):143-50. PubMed ID: 22771700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.
    Lanza-Jacoby S; Miller S; Jacob S; Heumann D; Minchenko AG; Flynn JT
    J Endotoxin Res; 2003; 9(6):341-7. PubMed ID: 14733720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes.
    Thirunavukkarasu C; Uemura T; Wang LF; Watkins SC; Gandhi CR
    J Cell Physiol; 2005 Aug; 204(2):654-65. PubMed ID: 15828022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo.
    Rettew JA; Huet YM; Marriott I
    Endocrinology; 2009 Aug; 150(8):3877-84. PubMed ID: 19406943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2.
    Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of toll-like receptor 4 (TLR4) by in vivo and in vitro exposure of rat epididymis to lipopolysaccharide from Escherichia Coli.
    Rodrigues A; Queiróz DB; Honda L; Silva EJ; Hall SH; Avellar MC
    Biol Reprod; 2008 Dec; 79(6):1135-47. PubMed ID: 18703421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
    Ohnishi T; Muroi M; Tanamoto K
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The systemic and pulmonary LPS binding protein response to intratracheal lipopolysaccharide.
    Gamble L; Bagby GJ; Quinton LJ; Happel KI; Mizgerd JP; Zhang P; Nelson S
    Shock; 2009 Feb; 31(2):212-7. PubMed ID: 18520704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity.
    Li P; Ho B; Ding JL
    J Endotoxin Res; 2007; 13(3):150-7. PubMed ID: 17621557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LPS, TLR4 and infectious disease diversity.
    Miller SI; Ernst RK; Bader MW
    Nat Rev Microbiol; 2005 Jan; 3(1):36-46. PubMed ID: 15608698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
    Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
    Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel TLR4-binding peptide that inhibits LPS-induced activation of NF-kappaB and in vivo toxicity.
    Sugiyama K; Muroi M; Tanamoto K
    Eur J Pharmacol; 2008 Oct; 594(1-3):152-6. PubMed ID: 18700140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation.
    Zhou H; Andonegui G; Wong CH; Kubes P
    J Immunol; 2009 Oct; 183(8):5244-50. PubMed ID: 19786543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic tests: Endotoxin (lipopolysaccharide: LPS)].
    Soda K; Kawakami M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():198-201. PubMed ID: 16111226
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation.
    Su GL
    Am J Physiol Gastrointest Liver Physiol; 2002 Aug; 283(2):G256-65. PubMed ID: 12121871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.